Robert Carey

Insider Reports History

Reporting-owner location: Richmond, CA
Latest reporting-owner signature: /s/ Robert Carey
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Carey

Form 4 holding Director

Beyond Air, Inc.

Security class: Common Stock
Shares / value: 4,076,864
Estimated value: $1,039,600
Report date: 14 Mar 2025
Price: $0.2550
Ownership: Direct

Form 4 holding Director

Beyond Air, Inc.

Security class: Common Stock
Shares / value: 1,476,626
Estimated value: $376,540
Report date: 14 Mar 2025
Price: $0.2550
Ownership: By The Carey 2020 Acelyrin Trust DTD 07/23/2020

Form 4 holding Director

SANGAMO THERAPEUTICS, INC

Security class: Common Stock
Shares / value: 99,600
Estimated value: $45,816
Report date: 12 Jun 2025
Price: $0.4600
Ownership: Direct

Form 4 holding Director

Beyond Air, Inc.

Security class: Warrants to purchase Common Stock
Shares / value: 494,332
Estimated value
Report date: 03 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

SANGAMO THERAPEUTICS, INC

Security class: Stock Option (Right to Buy)
Shares / value: 50,000
Estimated value
Report date: 12 Jun 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Beyond Air, Inc.

Security class: Stock Options (Right to buy)
Shares / value: 10,000
Estimated value
Report date: 04 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Robert Carey

4 XAIR

Beyond Air, Inc.

Report period: 05 Nov 2025
Transactions: 3
Transaction value: $0
Accepted by SEC: 07 Nov 2025, 16:05
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 04 Nov 2025
Transactions: 16
Transaction value: $0
Accepted by SEC: 07 Nov 2025, 16:05
Role: Director
Next action: Open filing details

4 SGMO

SANGAMO THERAPEUTICS, INC

Report period: 12 Jun 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 16 Jun 2025, 16:05
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 26 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Mar 2025, 17:12
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 14 Mar 2025
Transactions: 2
Transaction value: +$250,050
Accepted by SEC: 17 Mar 2025, 08:15
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 22 Nov 2024
Transactions: 14
Transaction value: $0
Accepted by SEC: 26 Nov 2024, 21:52
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 26 Sep 2024
Transactions: 6
Transaction value: +$744,662
Accepted by SEC: 01 Oct 2024, 21:58
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 14 Aug 2024
Transactions: 1
Transaction value: +$39,680
Accepted by SEC: 15 Aug 2024, 17:09
Role: Director
Next action: Open filing details

4 SGMO

SANGAMO THERAPEUTICS, INC

Report period: 04 Jun 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 06 Jun 2024, 16:23
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 20 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Mar 2024, 21:01
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 20 Mar 2024
Transactions: 2
Transaction value: +$1,000,001
Accepted by SEC: 21 Mar 2024, 08:30
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 18 Dec 2023
Transactions: 1
Transaction value: +$1,962,000
Accepted by SEC: 19 Dec 2023, 17:13
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 28 Aug 2023
Transactions: 1
Transaction value: +$673,750
Accepted by SEC: 29 Aug 2023, 16:10
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 18 Aug 2023
Transactions: 2
Transaction value: +$243,393
Accepted by SEC: 22 Aug 2023, 16:10
Role: Director
Next action: Open filing details

4 SGMO

SANGAMO THERAPEUTICS, INC

Report period: 01 Jun 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 05 Jun 2023, 16:47
Role: Director
Next action: Open filing details

5 XAIR

Beyond Air, Inc.

Report period: 31 Mar 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 14 Dec 2023, 21:12
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 29 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 31 Mar 2023, 16:15
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 29 Mar 2023
Transactions: 2
Transaction value: +$127,500
Accepted by SEC: 30 Mar 2023, 18:39
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 13 Mar 2023
Transactions: 2
Transaction value: +$94,164
Accepted by SEC: 15 Mar 2023, 16:05
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 08 Mar 2023
Transactions: 1
Transaction value: +$59,500
Accepted by SEC: 09 Mar 2023, 15:05
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 07 Dec 2022
Transactions: 1
Transaction value: +$115,000
Accepted by SEC: 09 Dec 2022, 15:15
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 28 Nov 2022
Transactions: 2
Transaction value: +$172,491
Accepted by SEC: 30 Nov 2022, 15:05
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 16 Nov 2022
Transactions: 3
Transaction value: +$294,000
Accepted by SEC: 18 Nov 2022, 19:35
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 30 Jun 2022
Transactions: 1
Transaction value: +$1,128,295
Accepted by SEC: 05 Jul 2022, 16:45
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 05 Apr 2022
Transactions: 1
Transaction value: +$134,200
Accepted by SEC: 06 Apr 2022, 16:15
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 24 Mar 2022
Transactions: 2
Transaction value: +$173,872
Accepted by SEC: 28 Mar 2022, 09:34
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 17 Mar 2022
Transactions: 1
Transaction value: +$135,000
Accepted by SEC: 21 Mar 2022, 16:32
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 03 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 07 Mar 2022, 07:33
Role: Director
Next action: Open filing details

4 SGMO

SANGAMO THERAPEUTICS, INC

Report period: 25 Feb 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 01 Mar 2022, 16:07
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 22 Dec 2021
Transactions: 1
Transaction value: +$95,000
Accepted by SEC: 27 Dec 2021, 15:15
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 23 Nov 2021
Transactions: 1
Transaction value: +$61,750
Accepted by SEC: 26 Nov 2021, 16:16
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 22 Nov 2021
Transactions: 1
Transaction value: +$120,500
Accepted by SEC: 24 Nov 2021, 15:10
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 19 Nov 2021
Transactions: 1
Transaction value: +$169,200
Accepted by SEC: 23 Nov 2021, 15:50
Role: Director
Next action: Open filing details

4 XAIR

Beyond Air, Inc.

Report period: 17 Jun 2021
Transactions: 1
Transaction value: +$1,876,000
Accepted by SEC: 21 Jun 2021, 16:21
Role: Director
Next action: Open filing details

5 XAIR

Beyond Air, Inc.

Report period: 31 Mar 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Feb 2022, 07:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .